4//SEC Filing
Quimi Daphne 4
Accession 0001209191-22-048797
CIK 0001178879other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:05 PM ET
Size
5.4 KB
Accession
0001209191-22-048797
Insider Transaction Report
Form 4
Quimi Daphne
Corporate Controller
Transactions
- Sale
Common Stock
2022-09-01$11.29/sh−4,397$49,621→ 335,312 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.99 to $11.57. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:05 PM ET
- Size
- 5.4 KB